Michael S. Ryan Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
233
+15
+7% +$15.3K 0.14% 51
2026
Q1
$201K Buy
218
+5
+2% +$5.07K 0.12% 55
2025
Q4
$229K Buy
+213
New +$204K 0.13% 50

Other funds holding LLY

Michael S. Ryan Inc's LLY Position: Q2 2026 in Review

Michael S. Ryan Inc increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $15.3K and bringing the position to 233 shares worth $279K. The position accounts for 0.14% of the portfolio, ranked #51.

Michael S. Ryan Inc first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,180 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Michael S. Ryan Inc held 233 shares of Eli Lilly worth $279K as of Q2 2026.
  • Michael S. Ryan Inc bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.14% of Michael S. Ryan Inc's portfolio in Q2 2026, its #51 holding.
  • Michael S. Ryan Inc first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,180 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Michael S. Ryan Inc's 13F filing for Q2 2026, filed 1 Jul 2026.